The Food and Drug Administration approved dronabinol, synthetic THC in sesame oil sold as Marinol; its approved uses are nausea and vomiting from chemotherapy and loss of appetite in HIV/AIDS. On 13 May 1986 the capsules were moved from Schedule I to Schedule II, and in 1999 to Schedule III. The plant itself stayed in Schedule I.[1]
Listed for context. No score change is recorded for United States here.
References
Checked. The date and the event were compared with a source that was read.